blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0203580

EP0203580 - Gamma-IFN as an agent for the inhibition (hindering) of the decay process of bones [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.11.1993
Database last updated on 03.10.2024
Most recent event   Tooltip11.11.1993No opposition filed within time limitpublished on 29.12.1993 [1993/52]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [1986/49]For all designated states
BOEHRINGER INGELHEIM INTERNATIONAL GmbH
D-55216 Ingelheim / DE
Inventor(s)01 / Peterlik, Meinrad, Prof. Dr.
Berggasse 25/28
A-1090 Wien / AT
02 / Hoffmann, Oskar
Buchengasse 17-19/41
A-1100 Wien / AT
[1986/49]
Application number, filing date86107225.428.05.1986
[1986/49]
Priority number, dateDE1985351936130.05.1985         Original published format: DE 3519361
[1986/49]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP0203580
Date:03.12.1986
Language:DE
[1986/49]
Type: A3 Search report 
No.:EP0203580
Date:06.07.1988
Language:DE
[1988/27]
Type: B1 Patent specification 
No.:EP0203580
Date:07.01.1993
Language:DE
[1993/01]
Search report(s)(Supplementary) European search report - dispatched on:EP17.05.1988
ClassificationIPC:A61K37/66
[1993/01]
CPC:
A61K38/217 (EP,US); A61P1/02 (EP); A61P19/10 (EP);
A61P3/00 (EP); A61P35/00 (EP); A61P43/00 (EP)
Former IPC [1986/49]A61K45/02
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1986/49]
TitleGerman:Gamma-IFN als Wirkstoff zur Hemmung (Verhinderung) von Abbauprozessen im Knochen[1986/49]
English:Gamma-IFN as an agent for the inhibition (hindering) of the decay process of bones[1986/49]
French:Gamma-IFN comme agent d'inhibition (d'empêchement) de processus de décomposition des os[1986/49]
Examination procedure14.12.1988Examination requested  [1989/06]
03.01.1992Despatch of a communication from the examining division (Time limit: M04)
09.03.1992Reply to a communication from the examining division
23.06.1992Despatch of communication of intention to grant (Approval: Yes)
08.07.1992Communication of intention to grant the patent
25.09.1992Fee for grant paid
25.09.1992Fee for publishing/printing paid
Opposition(s)08.10.1993No opposition filed within time limit [1993/52]
Fees paidRenewal fee
13.05.1988Renewal fee patent year 03
13.05.1989Renewal fee patent year 04
14.05.1990Renewal fee patent year 05
25.05.1991Renewal fee patent year 06
14.05.1992Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]EP0180737  (BIOFERON BIOCHEM SUBSTANZ [DE])
 [XP]  - FEBS LETT., Band 185, Nr. 2, Juni 1985, Seiten 287-290, Elsevier Science Publishers B.V.; M. PETERLIK et al.: "Recombinat gamma-interferon inhibits prostaglandin-mediated and parathyroid hormone-induced bone resorption in cultured neonatal mouse calvaria"
 [XP]  - THE JOURNAL OF IMMUNOLOGY, Band 136, Nr. 7, 1. April 1986, Seiten 2478-2481, The American Association of Immunologists, US; M. GOWEN et al.: "Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resoption in vitro"
 [X]  - FEBS LETT. Band 180, Nr. 1, Januar 1985, Seiten 43-50, Elsevier Science Publishers B.V.; M.L. STEPHENSON et al.: "Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of the procollagen mRNAs"
 [A]  - BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Band 120, Nr. 2, 30. April 1984, Seiten 553-558, Academic Press, Inc.; R.L. JILKA et al.: "Inhibition of parathormone-stimulated bone resorption by type 1 interferon"
 [A]  - JOURNAL OF INTERFERON RESEARCH, Band 4, Nr. 1, 1984, Seiten 135-140, Mary Ann Liebert, Inc., Publishers; O.S. NILSSON et al.: "Effect of interferon on heterotopic new bone formation in mice"
Examination   - Pathologie (3), R.Bässler , Böcker et al., S.764-769; Springer-Verlag 1984
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.